510(k) Report

PMA · Approved

Approved

Covera™ Vascular Covered Stent

P170042PMAApproved Jul 30, 2018230-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

C.R. Bard, Inc. · PFV System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment

Approved on Jul 30, 2018 through premarket approval, which rests on the device’s own clinical evidence after a 230-day review.

Decided
Jul 30, 2018
Review
230 days
Class
Class III
Product code
PFV
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P170042 has 14 supplements since 2018: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2018: 12019: 22020: 42021: 22022: 12023: 12025: 22026: 1
2018high 4 (2020) · low 0 (2024)2026
View FIG. 1 as a table
YearSupplements approved
20181
20192
20204
20212
20221
20231
20252
20261
FIG. 1 — Supplements to P170042, 2018–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PFV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All PFV devices

PFV System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · PFV

11in 2025

2007: 12008: 32009: 52010: 72011: 42012: 52013: 72014: 172015: 122016: 142017: 132018: 172019: 132020: 122021: 122022: 82023: 92024: 52025: 112026 (partial year): 5
2007high 17 (2014) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PFV

Too few PFV 510(k)s in any year since 2007 to give a median.

Recalls per year · PFV

No recall names PFV since 2007.

Adverse event reports per year · PFV

192in 2025

2014: 12015: 542016: 822017: 1952018: 3432019: 3762020: 3372021: 2812022: 2612023: 2292024: 2092025: 192
2007high 376 (2019) · low 0 (2007)2025

MAUDE reports naming product code PFV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20083—00
20095—00
20107—00
20114—00
20125—00
20137—00
201417—01
201512—054
201614—082
201713—0195
201817—0343
201913—0376
202012—0337
202112—0281
20228—0261
20239—0229
20245—0209
202511—0192
20265—0—
Cite this page

510(k) Report. “P170042: Covera™ Vascular Covered Stent.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P170042

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026